Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma - PubMed (original) (raw)
Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma
C F Manohar et al. Genes Chromosomes Cancer. 1995 Nov.
Abstract
MYCN gene amplification is strongly correlated with poor prognosis in neuroblastoma (NB), the second most common solid pediatric tumor. However, increased MYCN expression seen in tumors that lack MYCN amplification does not correlate with aggressive clinical behavior. Whereas the MYCN gene spans only 7 kb, the MYCN amplicon has been shown to range in size from 350 kb to more than 1 Mb. Given the large size of the amplicon, it is possible that additional genes are co-amplified in NBs whose expression may contribute to the aggressive phenotype associated with MYCN-amplified tumors. We isolated a cDNA clone from a human NB library that is identical to DDXI, a gene recently reported to be preferentially expressed in two retinoblastoma cell lines that also express high levels of MYCN. DDXI belongs to a family of genes that encode DEAD (Asp-Glu-Ala-Asp) box proteins, putative ATP-dependent RNA helicases implicated in a number of cellular processes involving alterations of RNA secondary structure. We examined the frequency of DDXI amplification in 15 NB cell lines, 1 neuroepithelioma cell line, and 122 NB tumors by Southern blot analyses, and we found that 7 of 10 MYCN-amplified cell lines and 27 of 40 (68%) MYCN-amplified tumors also harbored multiple copies of the DDXI gene. Amplification of DDXI was associated with high levels of DDXI mRNA expression in the NB cell lines and tumors as examined by Northern analysis. Neither DDXI gene amplification nor enhanced expression was observed in tumors or cell lines that lacked MYCN amplification. Because RNA helicases play important roles in both post-transcriptional and translational gene regulation, high levels of DDXI expression consequent to genomic amplification may contribute to the malignant phenotype of a subset of NBs.
Similar articles
- Relational mapping of MYCN and DDXI in band 2p24 and analysis of amplicon arrays in double minute chromosomes and homogeneously staining regions by use of free chromatin FISH.
Pandita A, Godbout R, Zielenska M, Thorner P, Bayani J, Squire JA. Pandita A, et al. Genes Chromosomes Cancer. 1997 Nov;20(3):243-52. doi: 10.1002/(sici)1098-2264(199711)20:3<243::aid-gcc4>3.0.co;2-2. Genes Chromosomes Cancer. 1997. PMID: 9365831 - Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma.
Squire JA, Thorner PS, Weitzman S, Maggi JD, Dirks P, Doyle J, Hale M, Godbout R. Squire JA, et al. Oncogene. 1995 Apr 6;10(7):1417-22. Oncogene. 1995. PMID: 7731693 - Relationship of DDX1 and NAG gene amplification/overexpression to the prognosis of patients with MYCN-amplified neuroblastoma.
Kaneko S, Ohira M, Nakamura Y, Isogai E, Nakagawara A, Kaneko M. Kaneko S, et al. J Cancer Res Clin Oncol. 2007 Mar;133(3):185-92. doi: 10.1007/s00432-006-0156-y. Epub 2006 Oct 7. J Cancer Res Clin Oncol. 2007. PMID: 17028906 - Genes co-amplified with MYCN in neuroblastoma: silent passengers or co-determinants of phenotype?
Scott D, Elsden J, Pearson A, Lunec J. Scott D, et al. Cancer Lett. 2003 Jul 18;197(1-2):81-6. doi: 10.1016/s0304-3835(03)00086-7. Cancer Lett. 2003. PMID: 12880964 Review. - Amplification of the MYCN oncogene and deletion of putative tumour suppressor gene in human neuroblastomas.
Schwab M. Schwab M. Brain Pathol. 1990 Sep;1(1):41-6. doi: 10.1111/j.1750-3639.1990.tb00637.x. Brain Pathol. 1990. PMID: 1669692 Review.
Cited by
- A MYCN-independent mechanism mediating secretome reprogramming and metastasis in _MYCN_-amplified neuroblastoma.
Zhang HF, Delaidelli A, Javed S, Turgu B, Morrison T, Hughes CS, Yang X, Pachva M, Lizardo MM, Singh G, Hoffmann J, Huang YZ, Patel K, Shraim R, Kung SHY, Morin GB, Aparicio S, Martinez D, Maris JM, Bosse KR, Williams KC, Sorensen PH. Zhang HF, et al. Sci Adv. 2023 Aug 25;9(34):eadg6693. doi: 10.1126/sciadv.adg6693. Epub 2023 Aug 23. Sci Adv. 2023. PMID: 37611092 Free PMC article. - The DEAD-box protein family of RNA helicases: sentinels for a myriad of cellular functions with emerging roles in tumorigenesis.
Ali MAM. Ali MAM. Int J Clin Oncol. 2021 May;26(5):795-825. doi: 10.1007/s10147-021-01892-1. Epub 2021 Mar 3. Int J Clin Oncol. 2021. PMID: 33656655 Review. - Clinical Importance of Myc Family Oncogene Aberrations in Epithelial Ovarian Cancer.
Jung M, Russell AJ, Kennedy C, Gifford AJ; Australian Ovarian Cancer Study Group; Mallitt KA, Sivarajasingam S, Bowtell DD, DeFazio A, Haber M, Norris MD, Henderson MJ. Jung M, et al. JNCI Cancer Spectr. 2018 Nov 16;2(3):pky047. doi: 10.1093/jncics/pky047. eCollection 2018 Jul. JNCI Cancer Spectr. 2018. PMID: 31360864 Free PMC article. - Loss of the Drosophila melanogaster DEAD box protein Ddx1 leads to reduced size and aberrant gametogenesis.
Germain DR, Li L, Hildebrandt MR, Simmonds AJ, Hughes SC, Godbout R. Germain DR, et al. Dev Biol. 2015 Nov 15;407(2):232-45. doi: 10.1016/j.ydbio.2015.09.012. Epub 2015 Oct 1. Dev Biol. 2015. PMID: 26433063 Free PMC article. - Ddx1 knockout results in transgenerational wild-type lethality in mice.
Hildebrandt MR, Germain DR, Monckton EA, Brun M, Godbout R. Hildebrandt MR, et al. Sci Rep. 2015 Apr 24;5:9829. doi: 10.1038/srep09829. Sci Rep. 2015. PMID: 25909345 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous